Dr. Reddy’s Strategic Acquisition of Haleon’s Nicotine Replacement Therapy Portfolio: A Game-Changer in the Global NRT Market
Dr. Reddy’s Strategic Acquisition of Haleon’s Nicotine Replacement Therapy Portfolio: A Game-Changer in the Global NRT Market In a significant move that underscores its commitment to expanding its global footprint, Dr. Reddy’s Laboratories has successfully acquired Haleon’s global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for a substantial sum of GBP 458 million. This … Read more